home / stock / argx / argx quote
Last: | $360.23 |
---|---|
Change Percent: | -0.55% |
Open: | $360.38 |
Close: | $360.23 |
High: | $362.535 |
Low: | $357.55 |
Volume: | 329,071 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$360.23 | $360.38 | $360.23 | $362.535 | $357.55 | 329,071 | 04-19-2024 |
$358.41 | $362.34 | $358.41 | $367.49 | $358.09 | 261,754 | 04-18-2024 |
$366.2 | $365.34 | $366.2 | $367.53 | $360.105 | 273,115 | 04-17-2024 |
$370.68 | $360.37 | $370.68 | $375.47 | $359.885 | 271,148 | 04-16-2024 |
$376.26 | $378.59 | $376.26 | $386.61 | $375.12 | 243,120 | 04-15-2024 |
$378.02 | $380.02 | $378.02 | $381.765 | $373.68 | 175,719 | 04-12-2024 |
$379.65 | $386.65 | $379.65 | $387.78 | $378.18 | 93,599 | 04-11-2024 |
$382.78 | $381.78 | $382.78 | $385.33 | $379.1 | 131,734 | 04-10-2024 |
$384.14 | $385.78 | $384.14 | $389.49 | $381.63 | 256,812 | 04-09-2024 |
$386.71 | $386.71 | $386.71 | $388.445 | $384.99 | 102,463 | 04-08-2024 |
$387.03 | $387.81 | $387.03 | $388.97 | $384.64 | 122,818 | 04-05-2024 |
$386.88 | $392.62 | $386.88 | $395.815 | $386.46 | 163,311 | 04-04-2024 |
$398.49 | $395.09 | $398.49 | $399.94 | $394.015 | 187,989 | 04-03-2024 |
$397.11 | $389.95 | $397.11 | $397.11 | $387.38 | 248,778 | 04-02-2024 |
$397.33 | $394.4 | $397.33 | $399.87 | $388.11 | 98,500 | 04-01-2024 |
$393.72 | $397.61 | $393.72 | $397.79 | $391.7 | 184,653 | 03-29-2024 |
$393.72 | $397.61 | $393.72 | $397.79 | $391.7 | 184,653 | 03-28-2024 |
$398.59 | $399.19 | $398.59 | $400.21 | $393.58 | 316,148 | 03-27-2024 |
$397.57 | $398.71 | $397.57 | $401.85 | $393.61 | 167,309 | 03-26-2024 |
$398.42 | $396.36 | $398.42 | $400.05 | $394.14 | 185,521 | 03-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
argenx SE Company Name:
ARGX Stock Symbol:
NASDAQ Market:
2024-04-18 12:15:04 ET Wells Fargo analyst issues SECTOR PERFORM recommendation for ARGX on April 18, 2024 10:01AM ET. The previous analyst recommendation was Sector Perform. ARGX was trading at $363.76 at issue of the analyst recommendation. The overall analyst consensu...
ADHERE data show VYVGART® Hytrulo has potential to be first advancement for CIDP patients in 30 years Real-world data demonstrate gMG patien...
ADHERE data show VYVGART ® Hytrulo has potential to be first advancement for CIDP patients in 30 years Real-world data demonstrate gMG patients able to significantly reduce steroid use over first six months of initiating VYVGART ® treatment April 16, 2024...